FCMT
EW icon

Founders Capital Management (Texas)’s Edwards Lifesciences EW Stock Holding History

Founders Capital Management (Texas)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-64
Closed -$6K – 393
2022
Q2 		$6K Buy
+64
New +$6.63K ﹤0.01% 350

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Founders Capital Management (Texas)'s EW Position: Q3 2022 in Review

Founders Capital Management (Texas) sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 64 shares — an estimated $6K sold.

Founders Capital Management (Texas) first reported a position in EW in Q2 2022 and held it in 1 quarter. The position peaked at $6K in Q2 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Founders Capital Management (Texas) reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 64 Edwards Lifesciences shares in Q3 2022, an estimated $6K.
  • Founders Capital Management (Texas) first reported a position in Edwards Lifesciences in Q2 2022 and held it in 1 quarter.
  • Founders Capital Management (Texas)'s Edwards Lifesciences position peaked at $6K in Q2 2022.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2022, filed 6 Oct 2022.